IDEXX raises forecast, betting diagnostics can offset weak vet visits

Impact · against what's priced in

IDEXX shares may see a modest lift as the company raises its forecast, signaling that diagnostics growth is successfully offsetting a decline in veterinary visit volumes. The positive revision suggests a resilience in the business model that may exceed previous market expectations.

IDXX+0.30: No priced-in read yet
In context: The company raised its financial forecast by leveraging diagnostics strength to counteract weak vet visit numbers, indicating a strong internal hedge against volume declines.
Read from the article alone

IDEXX raises forecast, betting diagnostics can offset weak vet visits

IDXX▲400%
forecast▲200%
healthcare
guidance
diagnostics
veterinary

Top 2 movers · tap to explore

IDEXX raises forecast, betting diagnostics can offset weak vet visits

How each ticker is affected

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

IDEXX raises forecast, betting diagnostics can offset weak vet visits

How each ticker is affected

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

Track these names every morning.

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?

Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates

Martin Marietta to Report Q3 Earnings: What to Expect This Season?

Cadence's Raised 2026 Outlook Tests the Strength of Its AI Demand

IDEXX raises forecast, betting diagnostics can offset weak vet visits

How each ticker is affected

Next reads from the same story arc

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

IDEXX raises forecast, betting diagnostics can offset weak vet visits

How each ticker is affected

Next reads from the same story arc

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

Track these names every morning.

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?

Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates

Martin Marietta to Report Q3 Earnings: What to Expect This Season?

Cadence's Raised 2026 Outlook Tests the Strength of Its AI Demand